Display options
Share it on

Hepat Mon. 2013 Nov 19;13(11):e12427. doi: 10.5812/hepatmon.12427. eCollection 2013.

Cholestasis and seizure due to lead toxicity: a case report.

Hepatitis monthly

Ali Mokhtarifar, Hooman Mozaffari, Reza Afshari, Ladan Goshayeshi, Kambiz Akavan Rezayat, Kamran Ghaffarzadegan, Mohammadreza Sheikhian, Farnood Rajabzadeh

Affiliations

  1. Gastroenterology and Hepatology Department, Mashhad University of Medical Sciences, Mashhad, IR Iran.
  2. Addiction Research Center, Mashhad University of Medical Sciences, Mashhad, IR Iran.
  3. Gastroenterology and Hepatology Department, Mashhad University of Medical Sciences, Mashhad, IR Iran ; Addiction Research Center, Mashhad University of Medical Sciences, Mashhad, IR Iran.
  4. Radiology Department, Mashhad Branch, Islamic Azad University, Mashhad, IR Iran.

PMID: 24348646 PMCID: PMC3860072 DOI: 10.5812/hepatmon.12427

Abstract

INTRODUCTION: Lead poisoning is a major public health risk which may involve major organs. Recently, there have been reports of opioid adulteration with lead in Iran. The following case report is the first of its kind in that intrahepatic cholestasis due to lead toxicity has been described.

CASE PRESENTATION: A 65-year-old man presented to the emergency department with abdominal pain, abnormal liver function tests (cholestatic pattern), and normocytic anemia. He had been an opium user for 20 years. Clinical and preclinical findings including the bluish discoloration of periodontal tissues, or Burton's sign, and generalized ileus on abdominal x-ray led us to the possibility of lead poisoning. Lead levels were higher than normal (150 μg/dL). Magnetic resonance cholangiopancreatography (MRCP) and abdominal ultrasound were performed to rule out extra hepatic causes of cholestasis. To evaluate the possibility of lead-induced hepatotoxicity, a liver biopsy was performed. Histological features of lead-induced hepatotoxity have rarely been described in humans. In this patient, focal canalicular cholestasis and mild portal inflammation were confirmed. Thus, treatment with ethylenediaminetetraacetic acid (EDTA) and British anti-lewisite (BAL) were initiated and continued for five days. The patient's liver function tests returned to their normal values, clinical findings including nausea, vomiting, and abdominal pain subsided, and the patient was discharged from the hospital in good condition.

CONCLUSIONS: Lead toxicity should always be taken into account in cases of intrahepatic cholestasis with an unknown etiology, especially in a setting where opium abuse is common.

Keywords: Cholestasis; Lead; Opium

References

  1. Clin Toxicol (Phila). 2012 Sep;50(8):791-2 - PubMed
  2. Indian J Med Res. 2007 Dec;126(6):518-27 - PubMed
  3. Daru. 2012 Oct 30;20(1):70 - PubMed
  4. J Toxicol Clin Toxicol. 2004;42(7):965-75 - PubMed
  5. Arch Iran Med. 2006 Jan;9(1):72-5 - PubMed
  6. Int J Occup Environ Med. 2010 Jan;1(1):29-38 - PubMed
  7. Iran Red Crescent Med J. 2012 Nov;14(11):737-42 - PubMed
  8. Scott Med J. 1979 Oct;24(4):318-21 - PubMed
  9. Interdiscip Toxicol. 2012 Jun;5(2):47-58 - PubMed
  10. Vet Hum Toxicol. 1998 Aug;40(4):203-7 - PubMed
  11. Drug Chem Toxicol. 2009;32(2):114-9 - PubMed
  12. West J Emerg Med. 2009 Nov;10(4):244-6 - PubMed
  13. Toxicology. 1998 Jul 17;128(3):181-9 - PubMed
  14. Toxicol Mech Methods. 2013 Jul;23(6):432-6 - PubMed
  15. Drug Chem Toxicol. 2010 Jan;33(1):48-9 - PubMed
  16. J Gastrointestin Liver Dis. 2009 Jun;18(2):225-7 - PubMed
  17. Vet Pathol. 1993 Nov;30(6):522-8 - PubMed
  18. Daru. 2012;20(1):2 - PubMed
  19. Singapore Med J. 2012 Jun;53(6):395-7 - PubMed

Publication Types